Actavis Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS LABS, and what generic and branded alternatives to ACTAVIS LABS drugs are available?
ACTAVIS LABS has one hundred and one approved drugs.
There are thirteen tentative approvals on ACTAVIS LABS drugs.
Drugs and US Patents for Actavis Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Fl | MESALAMINE | mesalamine | TABLET, DELAYED RELEASE;ORAL | 203817-001 | Mar 23, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Labs Fl Inc | CARTIA XT | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 074752-004 | Jul 9, 1998 | AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Labs Fl Inc | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 076049-003 | Jan 14, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Labs Ut Inc | FENTANYL-50 | fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 076709-002 | Aug 20, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Labs Fl Inc | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 076995-002 | Apr 27, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Actavis Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | LOXITANE IM | loxapine hydrochloride | INJECTABLE;INJECTION | 018039-001 | Approved Prior to Jan 1, 1982 | 3,546,226 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.